Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 4631-4648

  Fernandez Fernandez, Alicia ^a,b   Manchanda, Romila ^a,c   Carvajal, Denny A ^a,d   Lei, Tingjun ^a,e   Srinivasan, Supriya ^a   McGoron, Anthony J ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c GALGOTIAS UNIVERSITY   (India)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e Cirle   (United States)

Author keywords

Fluorescent imaging; Hyperthermia; Image guided therapy; Nanotechnology

Indexed keywords

ANTINEOPLASTIC AGENT; CYANINE DYE; DIAGNOSTIC AGENT; DIAMINE; DYE; INDOCYANINE GREEN; IR820; IR820 POLYETHYLENE GLYCOL DIAMINE NANOCONJUGATE; MACROGOL; NANOCONJUGATE; NEAR INFRARED DYE; UNCLASSIFIED DRUG; IR 820; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOACCUMULATION; BLEACHING; CIRCULATION TIME; CONTROLLED STUDY; COVALENT BOND; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; FLUORESCENCE MICROSCOPY; GROWTH INHIBITION; HYPERTHERMIA; IN VIVO STUDY; INTERNALIZATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PLASMA HALF LIFE; ULTRAVIOLET SPECTROPHOTOMETRY; ALGORITHM; ANALOGS AND DERIVATIVES; ANIMAL; CELL PROLIFERATION; CHEMISTRY; COMPUTER ASSISTED SURGERY; DRUG EFFECTS; FLUORESCENCE IMAGING; HUMAN; HYPERTHERMIC THERAPY; NANOTECHNOLOGY; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ALGORITHMS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DIAMINES; HUMANS; HYPERTHERMIA, INDUCED; INDOCYANINE GREEN; MICE; NANOCONJUGATES; NANOTECHNOLOGY; OPTICAL IMAGING; POLYETHYLENE GLYCOLS; SURGERY, COMPUTER-ASSISTED; TISSUE DISTRIBUTION;

EID: 84907882651     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S69550     Document Type: Article

References (59)

1. Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev. 2010;62(11):1064-1079.
2. Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol. 2011;165(7-8):1628-1651.
3. Janib SM, Moses AS, MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev. 2010;62(11):1052-1063.
4. Lu ZR. Theranostics: fusion of therapeutics and diagnostics. Pharm Res. 2014;31(6):1355-1357.
5. Wang D, Lin B, Ai H. Theranostic nanoparticles for cancer and cardiovascular applications. Pharm Res. 2014;31(6):1390-1406.
6. Ryu JH, Lee S, Son S, et al. Theranostic nanoparticles for future personalized medicine. J Control Release. 2014;190:477-484.
7. Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem. 2011;22(10):1879-1903.
8. Sumer B, Gao J. Theranostic nanomedicine for cancer. Nanomedicine (Lond). 2008;3(2):137-140.
9. Melancon MP, Stafford RJ, Li C. Challenges to effective cancer nanotheranostics. J Control Release. 2012;164(2):177-182.
10. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7(5):626-634.
11. Fernandez-Fernandez A, Manchanda R, Lei T, et al. Comparative study of the optical and heat generation properties of IR820 and indocyanine green. Mol Imaging. 2012;11(2):99-113.
12. Tang Y, Lei T, Manchanda R, et al. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study. Pharm Res. 2010;27(10): 2242-2253.
13. Srinivasan S, Manchanda R, Lei T, Nagesetti A, Fernandez-Fernandez A, McGoron AJ. Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents - an in vitro study. J Photochem Photobiol B. 2014;136:81-90.
14. Prajapati SI, Martinez CO, Bahadur AN, et al. Near-infrared imaging of injured tissue in living subjects using IR-820. Mol Imaging. 2009; 8(1):45-54.
15. Pandey RK, James N, Chen Y, Dobhal MP. Cyanine-based compounds for tumor imaging with and without photodynamic therapy. Top Heterocycl Chem. 2008;14:41-74.
16. Masotti A, Vicennati P, Boschi F, Calderan L, Sbarbati A, Ortaggi G. A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo. Bioconjug Chem. 2008;19(5): 983-987.
17. Thierry B, Al-Ejeh F, Khatri A, et al. Multifunctional core-shell magnetic cisplatin nanocarriers. Chem Commun (Camb). 2009;(47): 7348-7350.
18. Srinivasan S, Manchanda R, Fernandez-Fernandez A, Lei T, McGoron AJ. Near-infrared fluorescing IR820-chitosan conjugate for multifunctional cancer theranostic applications. J Photochem Photobiol B. 2013;119:52-59.
19. Lei T, Fernandez-Fernandez A, Manchanda R, Huang YC, McGoron AJ. Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heating. Beilstein J Nanotechnol. 2014;5:313-322.
20. Lei T, Manchanda R, Fernandez-Fernandez A, Huang YC, Wright D, McGoron AJ. Thermal and pH sensitive multifunctional polymer nanoparticles for cancer imaging and therapy. RSC Adv. 2014; 4(34):17959-17968.
21. Manchanda R, Fernandez-Fernandez A, Carvajal DA, Lei T, Tang Y, McGoron AJ. Nanoplexes for cell imaging and hyperthermia: in vitro studies. J Biomed Nanotechnol. 2012;8(4):686-694.
22. Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Delivery Rev. 2002;54(5):631-651.
23. Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci. 2006;61(3):1027-1040.
24. Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11(17-18):812-818.
25. Harris JM, Martin NE, Modi M. Pegylation: a novel process for modifying pharmacokinetics. Clin Pharmacokinet. 2001;40(7):539-551.
26. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505-515.
27. Hrkach JS, Peracchia MT, Domb A, Lotan N, Langer R. Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials. 1997;18(1):27-30.
28. Rajagopalan R, Uetrecht P, Bugaj JE, Achilefu SA, Dorshow RB. Stabilization of the optical tracer agent indocyanine green using noncovalent interactions. Photochem Photobiol. 2000;71(3):347-350.
29. Saxena V, Sadoqi M, Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm. 2006;308(1-2):200-204.
30. Yaseen MA, Yu J, Jung B, Wong MS, Anvari B. Biodistribution of encapsulated indocyanine green in healthy mice. Mol Pharm. 2009; 6(5):1321-1332.
31. Yamazaki M, Ito T. Deformation and instability in membrane structure of phospholipid vesicles caused by osmophobic association: mechanical stress model for the mechanism of poly(ethylene glycol)-induced membrane fusion. Biochemistry. 1990;29(5):1309-1314.
32. Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23(7):1553-1561.
33. Cavaliere R, Ciocatto EC, Giovanella BC, et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 1967;20(9): 1351-1381.
34. Luk KH, Hulse RM, Phillips TL. Hyperthermia in cancer therapy. West J Med. 1980;132(3):179-185.
35. Tang Y, McGoron AJ. Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells. J Photochem Photobiol B. 2009;97(3):138-144.
36. Tang Y, McGoron AJ. Increasing the rate of heating: a potential therapeutic approach for achieving synergistic tumour killing in combined hyperthermia and chemotherapy. Int J Hyperthermia. 2013;29(2): 145-155.
37. Van de Broek B, Devoogdt N, D’Hollander A, et al. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano. 2011;5(6):4319-4328.
38. Fukami T, Nakasu S, Baba K, Nakajima M, Matsuda M. Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell lines. J Neurooncol. 2004;70(3):319-331.
39. Ohnishi T, Takahashi A, Mori E, Ohnishi K. p53 Targeting can enhance cancer therapy via radiation, heat and anti-cancer agents. Anticancer Agents Med Chem. 2008;8(5):564-570.
40. Sturm I, Rau B, Schlag PM, et al. Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy. BMC Cancer. 2006;6:124.
41. Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine (Lond). 2011;6(4): 715-728.
42. Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5(4):496-504.
43. van Vlerken LE, Vyas TK, Amiji MM. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res. 2007;24(8):1405-1414.
44. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond). 2008;3(5):703-717.
45. Bazile D, Prud’homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M. Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci. 1995;84(4):493-498.
46. Gref R, Lück M, Quellec P, et al. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000;18(3-4):301-313.
47. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2): 283-318.
48. Peracchia MT, Harnisch S, Pinto-Alphandary H, et al. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials. 1999;20(14):1269-1275.
49. Scott MD, Murad KL. Cellular camouflage: fooling the immune system with polymers. Curr Pharm Des. 1998;4(6):423-438.
50. Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Surv Ophthalmol. 2000;45(1):15-27.
51. Mordon S, Devoisselle JM, Soulie-Begu S, Desmettre T. Indocyanine green: physicochemical factors affecting its fluorescence in vivo. Microvasc Res. 1998;55(2):146-152.
52. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1-16.
53. Arvizo RR, Miranda OR, Moyano DF, et al. Modulating pharmacokinetics, tumor uptake and biodistribution by engineered nanoparticles. PLoS One. 2011;6(9):e24374.
54. Liu D, Mori A, Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochim Biophys Acta. 1992;1104(1):95-101.
55. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14(5):1310-1316.
56. Dhanikula AB, Singh DR, Panchagnula R. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles. Curr Drug Deliv. 2005;2(1):35-44.
57. Berezhkovskiy LM. Determination of mean residence time of drug in plasma and the influence of the initial drug elimination and distribution on the calculation of pharmacokinetic parameters. J Pharm Sci. 2009; 98(2):748-762.
58. Fernandez-Fernandez A. IR820 Nanoconjugates for Theranostic Applications [PhD Dissertation]. Miami, FL: Biomedical Engineering, Florida International University; 2013.
59. Fernandez-Fernandez A, Manchanda R, Carvajal DA, Lei T, McGoron AJ. Covalent IR820-PEG diamine conjugates: characterization and in vivo biodistribution. Paper presented at: SPIE-BIOS 2013 (San Francisco, CA). Conference Proceedings - Proc. SPIE 8596, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications V, 859605 (February 21, 2013).